BIOPORTO DIAGNOSTICS A/S
18645882ActiveBioPorto develops diagnostic tools for early kidney injury detection.
Publicly traded biotechnology and medical device companybioporto.com
Yleiskatsaus
- 24
- Työntekijät
- Tuntematon
- Liikevaihto
- 1995
- Perustettu
Kuvaus
BioPorto is an in vitro diagnostics company dedicated to improving patient outcomes through the development of actionable biomarkers. The company specializes in the NGAL biomarker, which is used to aid in the risk assessment and diagnosis of Acute Kidney Injury (AKI). By leveraging expertise in anti...
Avainsanat
Acute Kidney InjuryAKIAntibodiesBiomarkersBioPortoBiotechnology
CALPRO AS